vidarabine has been researched along with Polyomavirus Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dave, SS; Kulbacki, E; McKinney, MS; Papalas, JA; Wang, E | 1 |
| Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
| Daly, A; Geddes, M; Lam, W; Li, H; Storek, J | 1 |
| Hiraoka, A; Karasuno, T; Kawakami, M; Maeda, T; Masaoka, T; Nakamura, H; Tanaka, K; Teshima, H; Ueda, S | 1 |
| Azzi, A; Bandini, G; De Santis, RD; Renga, M; Tosi, P; Tura, S; Vianelli, N | 1 |
| Caballero, MD; de la Loma, A; Del Cañizo, MC; Marcos, JM; Pérez-Simón, JA; San Miguel, JF; Seabra, C; Sierra, M; Vazquez, L | 1 |
6 other study(ies) available for vidarabine and Polyomavirus Infections
| Article | Year |
|---|---|
Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carcinoma, Merkel Cell; Cyclophosphamide; Diagnosis, Differential; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Merkel cell polyomavirus; Neoplasms, Multiple Primary; Polyomavirus Infections; Rituximab; Skin Neoplasms; Tumor Virus Infections; Vidarabine | 2014 |
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.
Topics: Adolescent; Adult; Aged; BK Virus; Busulfan; Cystitis; Cytomegalovirus Infections; Female; Graft vs Host Disease; HLA Antigens; Humans; Male; Middle Aged; Multivariate Analysis; Polyomavirus Infections; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Viremia; Young Adult | 2014 |
Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning.
Topics: Antilymphocyte Serum; BK Virus; Busulfan; Case-Control Studies; Cystitis; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Length of Stay; Male; Middle Aged; Myeloablative Agonists; Polyomavirus Infections; Recurrence; Risk Factors; Sex Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2017 |
Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation.
Topics: Adenoviridae Infections; Adult; Bone Marrow Transplantation; Cystitis; Female; Hematuria; Hemorrhage; Humans; Male; Middle Aged; Polyomavirus Infections; Urine; Vidarabine | 1997 |
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation.
Topics: Acute Disease; Antibiotic Prophylaxis; Bone Marrow Transplantation; Cystitis; Diarrhea; Fatal Outcome; Hematuria; Hemorrhage; Humans; Leukemia, Myeloid; Male; Middle Aged; Polyomavirus; Polyomavirus Infections; Time Factors; Transplantation, Homologous; Tumor Virus Infections; Vidarabine | 2000 |
Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation.
Topics: Adolescent; Antiviral Agents; BK Virus; Cystitis; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Injections, Intramuscular; Male; Polyomavirus Infections; Vidarabine | 2000 |